CN Stock MarketDetailed Quotes

Anhui Wanbang Pharmaceutical Technology (301520)

Watchlist
  • 42.27
  • +0.18+0.43%
Trading May 8 13:27 CST
2.82BMarket Cap115.81P/E (TTM)

Anhui Wanbang Pharmaceutical Technology (301520) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Clinical research service217.94M79.49%
Other34.43M12.56%
药学研究服务21.81M7.95%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
CRO行业274.18M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory274.18M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More